Vildagliptin also demonstrates a unique mechanism for Aβ and Tau clearance and reverses the cognitive deficits and pathology observed in AD possibly via modulating Klotho protein together with Akt pathway (Kosaraju et al., 2013b; Yossef et al., 2020). Here, MAPT is linked to Alzheimer disease.